BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33589427)

  • 1. Recreational substance use among patients with premature atherosclerotic cardiovascular disease.
    Mahtta D; Ramsey D; Krittanawong C; Al Rifai M; Khurram N; Samad Z; Jneid H; Ballantyne C; Petersen LA; Virani SS
    Heart; 2021 Apr; 107(8):650-656. PubMed ID: 33589427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
    Mahtta D; Ramsey DJ; Al Rifai M; Nasir K; Samad Z; Aguilar D; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    JAMA Netw Open; 2020 Aug; 3(8):e2011051. PubMed ID: 32816031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease.
    Lee MT; Mahtta D; Chen L; Hussain A; Al Rifai M; Sinh P; Khalid U; Nasir K; Ballantyne CM; Petersen LA; Virani SS
    Am J Med; 2021 Aug; 134(8):1047-1051.e2. PubMed ID: 33812865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
    Mahtta D; Lee MT; Ramsey DJ; Akeroyd JM; Krittanawong C; Khan SU; Sinh P; Alam M; Garratt KN; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):93-102. PubMed ID: 33400053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study.
    Jain V; Rifai MA; Brinzevich D; Taj M; Saleh M; Krittanawong C; Patel J; Patel A; Lee MT; Mahtta D; Virani SS
    Eur J Prev Cardiol; 2022 Mar; 29(3):493-501. PubMed ID: 34059910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?
    Mahtta D; Khalid U; Misra A; Samad Z; Nasir K; Virani SS
    Curr Atheroscler Rep; 2020 Jul; 22(9):44. PubMed ID: 32671484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Gooding HC; Ning H; Gillman MW; Shay C; Allen N; Goff DC; Lloyd-Jones D; Chiuve S
    JAMA Intern Med; 2017 Sep; 177(9):1354-1360. PubMed ID: 28715555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study.
    Florido R; Zhao D; Ndumele CE; Lutsey PL; McEvoy JW; Windham BG; Pankow JS; Guallar E; Michos ED
    J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry.
    Hejjaji V; Ellerbeck EF; Jones PG; Pacheco CM; Malik AO; Chan PS; Spertus JA; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009960. PubMed ID: 38318702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease.
    Lee MT; Mahtta D; Alam M; Ullah W; Nasir K; Hanif B; Virani SS
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):559-570. PubMed ID: 33565901
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between diseases of despair and atherosclerotic cardiovascular disease among insured adults in the USA: a retrospective cohort study from 2017 to 2021.
    Nudy M; Galper K; George DR; Williams BA; Kraschnewski JL; Sinoway L; Brignone E
    BMJ Open; 2023 Sep; 13(9):e074102. PubMed ID: 37673458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heartbeat: Recreational substance use and risk of premature atherosclerotic cardiovascular disease.
    Otto CM
    Heart; 2021 Apr; 107(8):599-601. PubMed ID: 33766852
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Calcium Improves Risk Assessment in Adults With a Family History of Premature Coronary Heart Disease: Results From Multiethnic Study of Atherosclerosis.
    Patel J; Al Rifai M; Blaha MJ; Budoff MJ; Post WS; Polak JF; Bluemke DA; Scheuner MT; Kronmal RA; Blumenthal RS; Nasir K; McEvoy JW
    Circ Cardiovasc Imaging; 2015 Jun; 8(6):e003186. PubMed ID: 26047825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dietary fatty acids with the risk of atherosclerotic cardiovascular disease in a prospective cohort of United States veterans.
    Ivey KL; Nguyen XT; Li R; Furtado J; Cho K; Gaziano JM; Hu FB; Willett WC; Wilson PW; Djoussé L
    Am J Clin Nutr; 2023 Oct; 118(4):763-772. PubMed ID: 37479185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of arterial stiffness index for the 10-year atherosclerotic cardiovascular disease risk determination in a middle-aged population-based study.
    Vallée A
    Clin Res Cardiol; 2023 Nov; 112(11):1679-1689. PubMed ID: 37650913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.